Biochemical assays with recombinant human MHC II molecules can provide rapid, quantitative insights into immunogenic epitope identification, deletion, or design. Here, a peptide-MHC II binding assay scaled to 384-well plates is described. This cost effective format should prove useful in the fields of protein deimmunization and vaccine design and development.
Salvat, R., Moise, L., Bailey-Kellogg, C., Griswold, K. E. A High Throughput MHC II Binding Assay for Quantitative Analysis of Peptide Epitopes. J. Vis. Exp. (85), e51308, doi:10.3791/51308 (2014).